0
A newer-generation stroke drug is outperforming the standard clot buster. A neurologist explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.
A newer-generation stroke drug is outperforming the standard clot buster. A neurologist explains how tenecteplase saves both time and money when it comes to treating ischemic stroke.